Please login to the form below

Not currently logged in
Email:
Password:

collaborations

This page shows the latest collaborations news and features for those working in and with pharma, biotech and healthcare.

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

LifeArc takes $30m equity stake in Kymab, gains access to antibody tech

This is thanks to LifeArc’s work (then known as MRC Technology) in humanising the mouse antibody on which Keytruda was based – thus the new Kymab collaboration is building on this

Latest news

More from news
Approximately 90 fully matching, plus 1,424 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    The firm has just signed a long-term collaboration with AZ for the discovery of new drugs for chronic kidney disease and idiopathic pulmonary fibrosis (IPF). ... Sam. “Dr Roberts is really driving a new spirit of collaboration between the industry and

  • Global direction, local application Global direction, local application

    Global strategy should be built deliberately to be adapted. Collaboration with your local teams will allow for this flexibility and ensure greater uptake.

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    The collaboration provides a cost and risk sharing approach to robust target validation and catalyses the collaboration between academic researchers, charity and pharmaceutical companies to translate novel drug targets towards the

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    Genomics England recently signed a £20m collaboration with IQVIA (under the auspices of the Life Sciences Sector Deal 2) to help bring the vision of UK clinical research and NHS treatment

  • Combining therapies and combining research Combining therapies and combining research

    With two candidates in phase 2 and a further one phase 2/3 ready, it has announced a collaboration with UCLA in which it will work closely to explore the commercial ... The collaboration will include the sharing of data, expertise and research methodology

More from intelligence
Approximately 51 fully matching, plus 238 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 58 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 159 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics